Questions about cancer? Freephone 1800 200 700 Irish Cancer Society Nurseline

About this trial

The purpose of this study is to assess if lenvatinib used with pembrolizumab are safe and effective in comparison to the best current available treatment.

Patient Profile

Advanced endometrial cancer

Where’s this trial being run?

Mater Misericordiae University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: MK3475-775
Number: CTRIAL-IE 19-09
Full Title:

A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with Advanced Endometrial Cancer

Principal Investigator: Dr Austin Duffy (Mater Misericordiae University Hospital)
Type: Industry Sponsored
Sponsor:

Merck Sharp & Dohme Corp.

Recruitment Started: Global: June 2018
Ireland: October 2018
Global Recruitment Target: 780
Ireland Recruitment Target: 5